Safely Returning to Clinical Trials
12 pm - 1:30 pm ET | 4 pm - 5:30 pm GMT
Since the coronavirus pandemic started, clinical trial recruitment and enrollment is down 40-60% across therapeutic areas. As the quarantine period ends, we are left with many questions about how to safely move forward with research, especially for patients suffering from serious, life-threatening diseases that might increase their risk of dying from COVID-19. This session will bring together the experts who sponsor, conduct, staff and recruit clinical trials to discuss the challenges and potential solutions that will enable continued access to novel, life-saving medications for patients around the world.
The session will take place on the newly formed COVID Advocacy Exchange platform created by GRYT Health, an award-winning digital health company in partnership with Bristol Myers Squibb. This new, entirely virtual platform will convene advocacy groups to synchronize efforts, facilitate resource sharing with each other and with patients, and provide a stepping stone to increased collaboration among all of us – both now and over the long-term.
Other upcoming sessions on the platform, all to be held at 12 pm - 1:30 pm ET | 4 pm - 5:30 pm GMT on the COVID Advocacy Exchange platform:
June 18 | Telemedicine & Access to Care
June 25 | Mental Health, Well-Being & Psychosocial Support
July 2 | Practical Solutions for Patients During COVID
July 9 | Preventive Care During COVID
July 16 | Reshaping Healthcare: Thinking Differently after COVID
July 23 | The Patient Voice & Patient-Focused Drug Development